Cargando…

Polygenic risk score for embryo selection—not ready for prime time

Numerous chronic diseases have a substantial hereditary component. Recent advances in human genetics have allowed the extent of this to be quantified via genome-wide association studies, producing polygenic risk scores (PRS), which can then be applied to individuals to estimate their risk of develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polyakov, Alex, Amor, David J, Savulescu, Julian, Gyngell, Christopher, Georgiou, Ektoras X, Ross, Vanessa, Mizrachi, Yossi, Rozen, Genia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527452/ https://www.ncbi.nlm.nih.gov/pubmed/35852518 http://dx.doi.org/10.1093/humrep/deac159

Ejemplares similares

Three models for the regulation of polygenic scores in reproduction
por: Munday, Sarah, et al.
Publicado: (2021)

“Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?
por: Ball, Robert, et al.
Publicado: (2022)

Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021)

Interpretable, not black-box, artificial intelligence should be used for embryo selection
por: Afnan, Michael Anis Mihdi, et al.
Publicado: (2021)

The moral imperative to continue gene editing research on human embryos
por: Savulescu, Julian, et al.
Publicado: (2015)

Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues
por: Lewis, Anna C. F., et al.
Publicado: (2021)

Management of incidental nodules in lung cancer screening: ready for prime-time?
por: Kanellakis, Nikolaos I., et al.
Publicado: (2019)

A double-blinded, randomized, placebo-controlled trial assessing the effects of nifedipine on embryo transfer: Study protocol
por: Ng, Kelvin KL, et al.
Publicado: (2017)

An overview of digital readiness in dentistry - are we ready?
por: Dickenson, Andrew, et al.
Publicado: (2022)

Are polygenic risk scores ready for the cancer clinic?—a perspective
por: Klein, Robert J., et al.
Publicado: (2022)

Does nifedipine improve outcomes of embryo transfer?: Interim analysis of a randomized, double blinded, placebo-controlled trial
por: Ng, Kelvin Kwok Lap, et al.
Publicado: (2019)

The Metaverse in Urology: Ready for Prime Time. The ESUT, ERUS, EULIS, and ESU Perspective
por: Checcucci, Enrico, et al.
Publicado: (2022)

Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines?
por: Gyngell, Christopher, et al.
Publicado: (2022)

Treatment outcomes of blastocysts thaw cycles, comparing the presence and absence of a corpus luteum: a systematic review and meta-analysis
por: Gan, Joscelyn, et al.
Publicado: (2022)

The Ethics of Germline Gene Editing
por: Gyngell, Christopher, et al.
Publicado: (2016)

Drugs, genes and screens: The ethics of preventing and treating spinal muscular atrophy
por: Gyngell, Christopher, et al.
Publicado: (2019)

Drawing the line on in vitro gametogenesis
por: Notini, Lauren, et al.
Publicado: (2019)

Great minds think different: Preserving cognitive diversity in an age of gene editing
por: Anomaly, Jonathan, et al.
Publicado: (2019)

Collective Reflective Equilibrium in Practice (CREP) and controversial novel technologies
por: Savulescu, Julian, et al.
Publicado: (2021)

Ethically utilising COVID-19 host-genomic data
por: Gyngell, Christopher, et al.
Publicado: (2021)

Germline gene editing and the precautionary principle
por: Koplin, Julian J., et al.
Publicado: (2019)

Real world evidence (RWE) - Are we (RWE) ready?
por: Suvarna, Viraj Ramesh
Publicado: (2018)

Operational Readiness of Data: The Next Challenge for Data Professionals?
por: Dharmawardena, Kheeran
Publicado: (2020)

Are We Ready for Coronavirus Disease 2019 Arriving at Schools?
por: Choe, Young June, et al.
Publicado: (2020)

Financing Drug Innovation in the US: Current Framework and Emerging Challenges
por: Cutler, David, et al.
Publicado: (2020)

Is mass spectrometry ready for proteome-wide protein expression analysis?
por: Rappsilber, Juri, et al.
Publicado: (2002)

The High-Throughput Analyses Era: Are We Ready for the Data Struggle?
por: D’Argenio, Valeria
Publicado: (2018)

How to Tell When a Digital Technology Is Not Ready for You
por: Crowcroft, Jon
Publicado: (2020)

Moral reasons to edit the human genome: picking up from the Nuffield report
por: Gyngell, Christopher, et al.
Publicado: (2019)

Subsidizing PGD: The Moral Case for Funding Genetic Selection
por: Kemper, James M., et al.
Publicado: (2019)

Polygenic risk scoring of human embryos: a qualitative study of media coverage
por: Pagnaer, Tiny, et al.
Publicado: (2021)

Radiology Readiness for Monkeypox: Experience From an Epicenter of the Public Health Emergency
por: Liszewski, Mark C., et al.
Publicado: (2022)

Non-invasive prenatal testing for ‘non-medical’ traits: ensuring consistency in ethical decision-making
por: Bowman-Smart, Hilary, et al.
Publicado: (2023)

Are We Ready for a True Biopsychosocial–Spiritual Model? The Many Meanings of “Spiritual”
por: Saad, Marcelo, et al.
Publicado: (2017)

The Ethics of Human Brain Organoid Transplantation in Animals
por: Kataoka, Masanori, et al.
Publicado: (2023)

Moving from ‘fully’ to ‘appropriately’ informed consent in genomics: The PROMICE framework
por: Koplin, Julian J., et al.
Publicado: (2022)

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
por: Evans, D. Gareth, et al.
Publicado: (2021)

The moral case for sign language education
por: Bowman-Smart, Hilary, et al.
Publicado: (2019)

Headaches and polygenic scores
por: Vilhjálmsson, Bjarni J., et al.
Publicado: (2019)

REBOA: is it ready for prime time?
por: Doucet, Jay, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c689bnvm5rp959bdquotr3ta2i